CPAP adherence after ambulatory and in-hospital management in patients aged 65 years and older.

IF 1.6 4区医学 Q2 Medicine

Acta Clinica Belgica Pub Date : 2023-12-01 Epub Date: 2023-10-16 DOI:10.1080/17843286.2023.2260137

Charlène Collard, Maxime Regnier, Gisèle Maury

{"title":"CPAP adherence after ambulatory and in-hospital management in patients aged 65 years and older.","authors":"Charlène Collard, Maxime Regnier, Gisèle Maury","doi":"10.1080/17843286.2023.2260137","DOIUrl":null,"url":null,"abstract":"Objectives: The aims of this study are to evaluate the early adherence to CPAP treatment in patients aged 65 years and older and to compare ambulatory (ACPAP) and in-hospital (HCPAP) management in starting CPAP treatment.Methods: Adherence to CPAP therapy at 3 months was retrospectively studied in patients on whom CPAP therapy was initiated between 1 January 2020 and 31 December 2021. Patients in the ACPAP group were selected based on the current Belgian reimbursement criteria (OAHI ≥30/h and few comorbidities).Results: 146 patients were studied (median OAHI 43.35/h [32.02; 57.40]; median age 69 [67.0; 73.0]): 116 (79.5%) patients in the HCPAP and 30 (20.5%) in the ACPAP group. Based on an adherence threshold of average CPAP use of ≥ 4 hours per day, 120 (82%) patients were adherent to the treatment; 94 (81%) patients in the HCPAP and 26 (86.7%) in the ACPAP group. The median CPAP use for the total population was 6.4 h/day [4.89; 7.34], reaching 6.3 h/d [4.79; 7.15] for the HCPAP group and 6.8 h/d [6.21; 8.06] for the ACPAP group (p = 0.019). Insomnia was a significant risk factor for non-adherence (OR 5.16 [1.64; 16.08], p = 0.0043) but the ACPAP method was not (OR 0.66 [0.18; 1.91], p = 0.4748).Conclusion: Early CPAP adherence in patients ≥ 65 years old was good in terms of average use per day and proportion of adherent patients. ACPAP method was not a risk factor for lower CPAP adherence in patients presenting severe OSAS (OAHI ≥30/h) and few comorbidities.","PeriodicalId":7086,"journal":{"name":"Acta Clinica Belgica","volume":" ","pages":"467-477"},"PeriodicalIF":1.6000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Clinica Belgica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/17843286.2023.2260137","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/10/16 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives: The aims of this study are to evaluate the early adherence to CPAP treatment in patients aged 65 years and older and to compare ambulatory (ACPAP) and in-hospital (HCPAP) management in starting CPAP treatment.

Methods: Adherence to CPAP therapy at 3 months was retrospectively studied in patients on whom CPAP therapy was initiated between 1 January 2020 and 31 December 2021. Patients in the ACPAP group were selected based on the current Belgian reimbursement criteria (OAHI ≥30/h and few comorbidities).

Results: 146 patients were studied (median OAHI 43.35/h [32.02; 57.40]; median age 69 [67.0; 73.0]): 116 (79.5%) patients in the HCPAP and 30 (20.5%) in the ACPAP group. Based on an adherence threshold of average CPAP use of ≥ 4 hours per day, 120 (82%) patients were adherent to the treatment; 94 (81%) patients in the HCPAP and 26 (86.7%) in the ACPAP group. The median CPAP use for the total population was 6.4 h/day [4.89; 7.34], reaching 6.3 h/d [4.79; 7.15] for the HCPAP group and 6.8 h/d [6.21; 8.06] for the ACPAP group (p = 0.019). Insomnia was a significant risk factor for non-adherence (OR 5.16 [1.64; 16.08], p = 0.0043) but the ACPAP method was not (OR 0.66 [0.18; 1.91], p = 0.4748).

Conclusion: Early CPAP adherence in patients ≥ 65 years old was good in terms of average use per day and proportion of adherent patients. ACPAP method was not a risk factor for lower CPAP adherence in patients presenting severe OSAS (OAHI ≥30/h) and few comorbidities.

查看原文本刊更多论文

65岁及以上患者门诊和住院治疗后的CPAP依从性。

目的：本研究的目的是评估65岁患者对CPAP治疗的早期依从性并比较门诊（ACPAP）和住院（HCPAP）在开始CPAP治疗中的管理。方法：3岁时坚持CPAP治疗对2020年1月1日至2021年12月31日期间开始CPAP治疗的患者进行了月回顾性研究。ACPAP组的患者是根据目前比利时的报销标准（OAHI≥30/h且很少合并症）选择的。结果：研究了146名患者（OAHI中位数43.35/h[32.02；57.40]；中位年龄69[67.0；73.0]）：HCPAP组116名（79.5%）患者，ACPAP组30名（20.5%）患者。基于CPAP平均使用的依从性阈值 ≥ 4. 每天小时，120名（82%）患者坚持治疗；HCPAP组94例（81%），ACPAP组26例（86.7%）。总人群的CPAP使用中位数为6.4 h/天[4.89；7.34]，达到6.3 HCPAP组的h/d[4.79；7.15]和6.8 ACPAP组的h/d[6.21；8.06]（p = 失眠是不依从性的重要危险因素（OR 5.16[1.64；16.08]，p = 0.0043），而ACPAP方法不是（OR 0.66[0.18；1.91]，p = 0.4748）。结论：患者早期坚持CPAP ≥ 65 就每天的平均使用量和粘连患者的比例而言，岁是好的。ACPAP方法不是严重OSAS（OAHI≥30/h）和少数合并症患者CPAP依从性较低的危险因素。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Acta Clinica Belgica 医学-医学：内科

CiteScore

2.90

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine primarily publishes papers on clinical medicine, clinical chemistry, pathology and molecular biology, provided they describe results which contribute to our understanding of clinical problems or describe new methods applicable to clinical investigation. Readership includes physicians, pathologists, pharmacists and physicians working in non-academic and academic hospitals, practicing internal medicine and its subspecialties.